Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Siebert S et al
(Nov.2024) Semaglutide, a GLP-1 medication, is the first weight loss medication approved to reduce the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are overweight or obese.
These represent the safest entry points with the best risk-to-benefit ratios
These bundled prices may appear higher than medication-only prices but can represent good value when the full cost of treatment is considered
Who May Be a Candidate for GLP-1 Weight-Loss Injections
US$ 26.90
US$ 28.84
US$ 24.88
US$ 24.65
US$ 26.46
US$ 28.63
US$ 24.14
